$39.520
+1.016 (+2.57%)At close
OKLO News
OKLO Events
Oklo Inc Shares Rise 1.08% to $39.95
Cboe data suggests bullish flow in Oklo Inc (OKLO), with shares up 42c, or 1.08%, near $39.95. Options volume running well above average with 74k contracts traded and calls leading puts for a put/call ratio of 0.13, compared to a typical level near 0.59. Implied volatility (IV30) is higher by 0.1 points near 68.99,in the lowest 10% of observations over the past year, suggesting an expected daily move of $1.74. Put-call skew flattened, suggesting a modestly bullish tone.
Oklo Inc Shares Rise $1.38 to $42.98
Moderately bullish activity in Oklo Inc (OKLO), with shares up $1.38, or 3.31%, near $42.98. Options volume roughly in line with average with 26k contracts traded and calls leading puts for a put/call ratio of 0.25, compared to a typical level near 0.58. Implied volatility (IV30) dropped 1.25 near 76.8,in the lowest 10% of observations over the past year, suggesting an expected daily move of $2.08. Put-call skew flattened, suggesting a modestly bullish tone.
Company Reports Q2 Revenue of $1.2M
Reports Q2 revenue $1.2M, consensus $71.83k.
Oklo Achieves First Criticality in Groves Isotope Test Reactor
Oklo announced that its Groves Isotope Test Reactor has achieved first criticality after achieving a controlled, self-sustaining nuclear chain reaction at low power. The milestone comes less than a year after groundbreaking and follows U.S. Department of Energy, DOE, authorization through the DOE Reactor Pilot Program, RPP. "Reaching criticality in less than a year is an incredible milestone for our team," said Oklo co-founder and CEO Jacob DeWitte. "Oklo developed Groves from a greenfield site on private land, completed full-scale civil excavation and construction, manufactured or commercially procured all components, including fuel, and developed its operating programs in-house. Taken together, we believe these accomplishments establish a new benchmark for the Reactor Pilot Program and set the stage for the future of advanced nuclear deployment at scale."
Oklo Receives Startup Authorization for Groves Isotope Test Reactor
Oklo announced it received startup authorization for its Groves Isotope Test Reactor. This authorization, granted under the U.S. Department of Energy Reactor Pilot Program, completes DOE's authorization process and clears the way for fuel loading, startup testing, and reactor operations. Groves is a low-power test reactor designed to demonstrate reactor design, build, and operations, and to establish operating experience needed to support future isotope production facilities. The project advances Oklo's plans to establish domestic production of critical isotopes for potential use in cancer care, manufacturing, scientific research, space exploration, and national security. "This facility marks the fastest time that we are aware of to go from greenfield to substantial completion for a full-scale, privately funded and sited reactor in history," said Oklo co-founder and CEO Jacob DeWitte. "By building on a greenfield site on private land, performing full-scale civil excavation and construction, and procuring fuel and all major components commercially, we demonstrated that the advanced nuclear industry can move at a pace that many did not believe possible. And this experience is fully translatable to future commercial deployments."
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.